ACSL3 Promotes Hepatocellular Carcinoma Tumorigenesis and Correlates With JAK–STAT3 Signaling

ABSTRACT Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapies. Reprogrammed lipid metabolism, driven by upregulated de novo lipogenesis, is a key tumorigenic mechanism. The enzyme ACSL3 is strongly correlated with poor HCC prognosis, positioning it...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Melika Amelimojarad, Mandana Amelimojarad, Alireza Pourmahdian, Zhang Lu
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Wiley 2026-02-01
Цуврал:	Cancer Medicine
Нөхцлүүд:	ACSL3 LDs lipid metabolism liver cancer
Онлайн хандалт:	https://doi.org/10.1002/cam4.71543
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!